VENTED MILLEX -GV, CATHIVEX -GV— 510(k) K133004

Substantially Equivalent

Merck Millipore , Ltd.

FDA 510(k) clearance K133004 for VENTED MILLEX -GV, CATHIVEX -GV, Substantially Equivalent on 2014-03-27. Applicant: Merck Millipore , Ltd..

Clearance details

Applicant: Merck Millipore , Ltd.
Product code: Code BSN
Advisory panel: Anesthesiology
Date received: 2013-09-25
Decision date: 2014-03-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Temecula, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.